141 related articles for article (PubMed ID: 1084176)
21. [Morphology and adenosine phosphate in experimental nephrocalcinosis].
Lunglmayr G; Schwarzmeier J
Z Gesamte Exp Med Einschl Exp Chir; 1968; 148(3):204-9. PubMed ID: 5728873
[No Abstract] [Full Text] [Related]
22. [Experimental studies on nephrocalcinosis].
Gasser G; Kenner T; Waldhäusl W
Urologe; 1968; 7(1):68-71. PubMed ID: 5654490
[No Abstract] [Full Text] [Related]
23. On mechanism of urate kidney stone formation.
Noda S
Scan Electron Microsc; 1984; (Pt 4):1801-8. PubMed ID: 6523054
[TBL] [Abstract][Full Text] [Related]
24. [Development of calcinosis of the kidneys and the aorta in rats with various ratios of Ca to P in their rations].
Blazheevich NV; Spirichev VB; Pozdniakov AL; Isaeva VA; Gazdarov AK
Vopr Pitan; 1974; 0(5):28-34. PubMed ID: 4428667
[No Abstract] [Full Text] [Related]
25. [Changes in nephron structure in experimental nephrocalcinosis].
Dunchik VN; Sviridova TV
Urol Nefrol (Mosk); 1968; 33(4):3-6. PubMed ID: 5747138
[No Abstract] [Full Text] [Related]
26. [Does vitamin E protect against experimental lithiasis?].
Sakly A; Achour A; Zouaghi H
Ann Urol (Paris); 1994; 28(5):265-7. PubMed ID: 7825984
[TBL] [Abstract][Full Text] [Related]
27. The ultrastructure of nephrocalcinosis induced in chicks by Cestrum diurnum leaves.
Sarkar K; Narbaitz R; Pokrupa R; Uhthoff HK
Vet Pathol; 1981 Jan; 18(1):62-70. PubMed ID: 7467073
[TBL] [Abstract][Full Text] [Related]
28. [Inherited monogenic kidney stone diseases: recent diagnostic and therapeutic advances].
Jungers P; Joly D; Blanchard A; Courbebaisse M; Knebelmann B; Daudon M
Nephrol Ther; 2008 Jul; 4(4):231-55. PubMed ID: 18499551
[TBL] [Abstract][Full Text] [Related]
29. [Experimental oxalic lithiasis induced with ethylene glycol in rats. Its value in trial hypooxaluric treatment].
Melon JM; Thomas J
Therapie; 1971; 26(5):985-90. PubMed ID: 5160350
[No Abstract] [Full Text] [Related]
30. Nephrocalcinosis: molecular insights into calcium precipitation within the kidney.
Sayer JA; Carr G; Simmons NL
Clin Sci (Lond); 2004 Jun; 106(6):549-61. PubMed ID: 15027893
[TBL] [Abstract][Full Text] [Related]
31. Exacerbation of nephrolithiasis by a carbonic anhydrase inhibitor.
Wallace MR; MacDiarmid J; Reeder J
N Z Med J; 1974 Feb; 79(509):687-90. PubMed ID: 4522951
[No Abstract] [Full Text] [Related]
32. The renal papilla in calculogenesis of oxamide stones.
Borden TA; Vermeulen CW
Invest Urol; 1966 Sep; 4(2):125-32. PubMed ID: 5951299
[No Abstract] [Full Text] [Related]
33. [Study on mechanism of urate stone formation. II. Electron microscopic study (author's transl)].
Miyoshi N
Nihon Hinyokika Gakkai Zasshi; 1978 Oct; 69(10):1258-75. PubMed ID: 732061
[No Abstract] [Full Text] [Related]
34. Induction of nephrocalcinosis in rabbit kidneys after long-term exposure to a streptococcal teichoic acid.
Waltersdorff RL; Fiedel BA; Jackson RW
Infect Immun; 1977 Sep; 17(3):665-7. PubMed ID: 332635
[TBL] [Abstract][Full Text] [Related]
35. [Experimental oxalic lithiasis induced with glyoxylic acid in rats. Attempted prevention with succinimide].
Melon JM; Thomas J; Pierre R
Therapie; 1971; 26(5):991-8. PubMed ID: 5160351
[No Abstract] [Full Text] [Related]
36. Experimental calcium oxalate nephrolithiasis in the rat. Role of the renal papilla.
Khan SR; Finlayson B; Hackett RL
Am J Pathol; 1982 Apr; 107(1):59-69. PubMed ID: 7065125
[TBL] [Abstract][Full Text] [Related]
37. Oxalate in renal stone disease: the terminal metabolite that just won't go away.
Marengo SR; Romani AM
Nat Clin Pract Nephrol; 2008 Jul; 4(7):368-77. PubMed ID: 18523430
[TBL] [Abstract][Full Text] [Related]
38. Furosemide nephrolithiasis causing ureteral obstruction and urinoma in a preterm neonate.
Alpert SA; Noe HN
Urology; 2004 Sep; 64(3):589. PubMed ID: 15351602
[TBL] [Abstract][Full Text] [Related]
39. Nephrocalcinosis, Renal Dysfunction, and Calculi in Patients With Primary Hypoparathyroidism on Long-Term Conventional Therapy.
Saha S; Kandasamy D; Sharma R; Bal C; Sreenivas V; Goswami R
J Clin Endocrinol Metab; 2020 Apr; 105(4):. PubMed ID: 31901096
[TBL] [Abstract][Full Text] [Related]
40. Crystal retention in renal stone disease: a crucial role for the glycosaminoglycan hyaluronan?
Verkoelen CF
J Am Soc Nephrol; 2006 Jun; 17(6):1673-87. PubMed ID: 16707562
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
